Concepedia

Efrat Harel

EH

Statistics

Publications

5

Citations

180

H-Index

5

Active since

2011

Affiliations

University of California, San Francisco(Current)

UCSF Helen Diller Family Comprehensive Cancer Center

AbbVie (United States)

Efrat Harel is an author at University of California, San Francisco specializing in medicine, kidney transplantation, and cell biology.

ORCID

Publications per year

2011–2019

5

Publications

5

Enhanced Transferrin Receptor Expression by Proinflammatory Cytokines in Enterocytes as a Means for Local Delivery of Drugs to Inflamed Gut Mucosa

Efrat Harel, Abraham Rubinstein, Aviram Nissan et al. · PLoS ONE · 2011 · 80 citations · Full text

, , +17

Urokinase-type Plasminogen Activator Receptor (uPAR) Ligation Induces a Raft-localized Integrin Signaling Switch That Mediates the Hypermotile Phenotype of Fibrotic Fibroblasts

L. Grove, Brian D. Southern, Tong Huan Jin et al. · Journal of Biological Chemistry · 2014 · 37 citations · Full text

, , +17

Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer

Efrat Harel, Penelope M. Drake, Robyn M. Barfield et al. · Antibodies · 2019 · 31 citations · Full text

, , +17

Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes

Efrat Harel, Jun Shoji, Vivek C. Abraham et al. · Transplantation · 2019 · 20 citations · Full text

, , +17

Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation

Efrat Harel, Jun Shoji, Vivek C. Abraham et al. · Clinical Transplantation · 2019 · 12 citations

, , +15

1–5 of 5